跳转至内容
Merck

H0325000

海克替啶

European Pharmacopoeia (EP) Reference Standard

别名:

海克替啶,立体异构体混合物, 5-氨基-1,3-双(2-乙己基)六氢-5-甲基嘧啶, NSC 17764

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C21H45N3
CAS号:
分子量:
339.60
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

hexetidine

製造商/商標名

EDQM

折射率

n20/D 1.4649 (lit.)

bp

160 °C/0.4 mmHg (lit.)

密度

0.889 g/mL at 25 °C (lit.)

應用

pharmaceutical (small molecule)

格式

neat

儲存溫度

2-8°C

SMILES 字串

CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1

InChI

1S/C21H45N3/c1-6-10-12-19(8-3)14-23-16-21(5,22)17-24(18-23)15-20(9-4)13-11-7-2/h19-20H,6-18,22H2,1-5H3

InChI 密鑰

DTOUUUZOYKYHEP-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

應用

参与研究:
  • 鉴定(identify)阿司匹林的纯液体盐形式
  • 作为基于烷基的选择性置换剂候选,用于离子交换色谱法蛋白纯化
  • 体内应用模型,用于试验非复制结核分枝杆菌抗性药物
  • 将能量代谢从线粒体呼吸转变为糖酵解的药物的营养敏化筛选
  • 血管形成抑制
  • 抗疟药物筛选

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

相關產品

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

158.0 °F - closed cup

閃點(°C)

70 °C - closed cup


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Elvedina Kapić et al.
Medicinski arhiv, 56(1), 43-48 (2002-03-29)
Hexetidine is very safe oral antiseptic with broad antibacterial and antifungal activity in vivo and in vitro. It has local-anesthetics, astringent and deodorant activity. Also, it has very strong antiplac effects. Resistention of microorganisms on hexetidine is short and transient.
F Afennich et al.
International journal of dental hygiene, 9(3), 182-190 (2011-03-02)
To review the literature concerning hexetidine-containing mouthwash as a monotherapy or as an adjunct to oral hygiene in the prevention of plaque accumulation and gingival inflammation. PubMed-MEDLINE and the Cochrane-CENTRAL were searched through January 2010 to identify appropriate studies. The
Andreas Peyrl et al.
Journal of neuro-oncology, 120(1), 139-145 (2014-07-16)
The Ommaya reservoir facilitates repetitive delivery of drugs into the CSF and is a pharmacologically rational system for intrathecal chemotherapy. Because previous studies have found a high rate of infection and other complications we herein studied our experience with this
Synergistic antiplaque effects of a zinc fluoride/hexetidine containing mouthwash. A review.
U P Saxer et al.
Schweizerische Monatsschrift fur Zahnheilkunde = Revue mensuelle suisse d'odonto-stomatologie, 93(8), 689-704 (1983-08-01)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门